blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2362777

EP2362777 - USE OF PHARMACEUTICAL COMPOSITIONS IN PREPARING PHARMACEUTICALS FOR TREATING DIABETIC ULCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.05.2015
Database last updated on 30.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK
published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Xu, Rongxiang
F31 Building A The Spaces International Center 8 Dongdaqiao Street
Chaoyang District, Beijing 100020 / CN
[2014/29]
Former [2011/36]For all designated states
Xu, Rongxiang
F31 Building A The Spaces International Center 8 Dongdaqiao Street
Chaoyang District, Beijing 100020 / CN
Inventor(s)01 / see applicant
...
 [2011/36]
Representative(s)Danner, Stefan, et al
LifeTech IP
Spies Danner & Partner
Patentanwälte PartG mbB
Elsenheimerstrasse 47a
80687 München / DE
[2014/29]
Former [2014/11]Danner, Stefan, et al
LifeTech IP
Spies Danner & Partner Patentanwälte PartG mbB
Sankt-Martin-Strasse 53-55
81669 München / DE
Former [2013/12]Danner, Stefan, et al
DR. VOLKER VOSSIUS
Patent- und Rechtsanwaltskanzlei
Partnerschaft
Geibelstraße 6
81679 München / DE
Former [2013/10]Danner, Stefan
Dr. Volker Vossius
Patentanwälte - Rechtsanwälte
Partnerschaftsgesellschaft
Geibelstraße 6
81679 München / DE
Former [2011/36]Dilg, Haeusler, Schindelmann Patentanwaltsgesellschaft mbH
Leonrodstrasse 58
80636 München / DE
Application number, filing date10809445.920.01.2010
WO2010CN70263
Priority number, dateCN2009109135520.08.2009         Original published format: CN200910091355
[2011/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011020311
Date:24.02.2011
Language:EN
[2011/08]
Type: A1 Application with search report 
No.:EP2362777
Date:07.09.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 24.02.2011 takes the place of the publication of the European patent application.
[2011/36]
Type: B1 Patent specification 
No.:EP2362777
Date:16.07.2014
Language:EN
[2014/29]
Search report(s)International search report - published on:CN24.02.2011
(Supplementary) European search report - dispatched on:EP25.07.2012
ClassificationIPC:A61K36/75, A61K36/718, A61K36/66, A61K36/481, A61K36/185, A61K35/64, A61K9/06, A61K9/107, A61P17/02
[2011/36]
CPC:
A61F13/01012 (EP,US); A61K36/481 (KR); A61K36/75 (KR,US);
A61F13/00063 (EP,US); A61F13/00072 (EP,US); A61F13/069 (EP,US);
A61K35/62 (EP,US); A61K35/644 (EP,US); A61K36/185 (EP,US);
A61K36/539 (EP,US); A61K36/66 (EP,KR,US); A61K36/71 (US);
A61K36/718 (EP,KR,US); A61K36/756 (EP,US); A61K47/44 (US);
A61K9/0014 (EP,US); A61K9/06 (EP,US); A61L15/34 (EP,US);
A61L15/40 (US); A61L15/44 (US); A61P1/04 (EP);
A61P17/02 (EP); A61P25/00 (EP); A61P3/10 (EP);
A61P37/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61F2013/00161 (EP,US); A61F2013/0054 (EP,US); A61F2013/0091 (EP,US);
A61F2013/00927 (EP,US) (-)
C-Set:
A61K35/62, A61K2300/00 (EP,US);
A61K35/644, A61K2300/00 (EP,US);
A61K36/185, A61K2300/00 (US,EP);
A61K36/539, A61K2300/00 (US,EP);
A61K36/66, A61K2300/00 (US,EP);
A61K36/718, A61K2300/00 (US,EP);
A61K36/756, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2014/29]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:VERWENDUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN BEI DER HERSTELLUNG VON ARZNEIMITTELN ZUR BEHANDLUNG VON DIABETISCHEM GESCHWÜR[2011/36]
English:USE OF PHARMACEUTICAL COMPOSITIONS IN PREPARING PHARMACEUTICALS FOR TREATING DIABETIC ULCER[2011/36]
French:UTILISATION DE COMPOSITIONS PHARMACEUTIQUES DANS LA PRÉPARATION DE PRODUITS PHARMACEUTIQUES POUR TRAITER LES ULCÈRES DIABÉTIQUES[2011/36]
Entry into regional phase31.05.2011National basic fee paid 
31.05.2011Search fee paid 
31.05.2011Designation fee(s) paid 
31.05.2011Examination fee paid 
Examination procedure31.05.2011Examination requested  [2011/36]
30.11.2012Amendment by applicant (claims and/or description)
03.09.2013Despatch of a communication from the examining division (Time limit: M04)
18.11.2013Reply to a communication from the examining division
23.04.2014Communication of intention to grant the patent
19.05.2014Fee for grant paid
19.05.2014Fee for publishing/printing paid
19.05.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.09.2013
Opposition(s)17.04.2015No opposition filed within time limit [2015/26]
Fees paidRenewal fee
14.12.2011Renewal fee patent year 03
24.01.2013Renewal fee patent year 04
02.01.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.01.2010
AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
HR16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MK16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
SM16.07.2014
TR16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE20.01.2015
LU20.01.2015
CH31.01.2015
LI31.01.2015
[2018/30]
Former [2017/38]HU20.01.2010
AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
HR16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
SM16.07.2014
TR16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE20.01.2015
LU20.01.2015
CH31.01.2015
LI31.01.2015
Former [2017/03]AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
MT16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE20.01.2015
LU20.01.2015
CH31.01.2015
LI31.01.2015
Former [2016/32]AT16.07.2014
BE16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE20.01.2015
LU20.01.2015
CH31.01.2015
LI31.01.2015
Former [2016/07]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
IE20.01.2015
LU20.01.2015
BE31.01.2015
CH31.01.2015
LI31.01.2015
Former [2015/50]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SI16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU20.01.2015
BE31.01.2015
CH31.01.2015
LI31.01.2015
Former [2015/47]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU20.01.2015
BE31.01.2015
CH31.01.2015
LI31.01.2015
Former [2015/43]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
MC16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU20.01.2015
BE31.01.2015
Former [2015/39]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
LU20.01.2015
BE31.01.2015
Former [2015/30]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
BE31.01.2015
Former [2015/23]AT16.07.2014
CY16.07.2014
CZ16.07.2014
DK16.07.2014
EE16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
SK16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/22]AT16.07.2014
CY16.07.2014
DK16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
RO16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/12]AT16.07.2014
CY16.07.2014
FI16.07.2014
LT16.07.2014
LV16.07.2014
NL16.07.2014
PL16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
IS16.11.2014
PT17.11.2014
Former [2015/11]CY16.07.2014
FI16.07.2014
LT16.07.2014
PL16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
GR17.10.2014
PT17.11.2014
Former [2015/10]FI16.07.2014
LT16.07.2014
SE16.07.2014
BG16.10.2014
NO16.10.2014
Former [2015/09]FI16.07.2014
LT16.07.2014
SE16.07.2014
Former [2015/08]LT16.07.2014
Documents cited:Search[Y]CN101069753  ;
 [A]EP0606786  (XU RONGXIANG [CN]) [A] 1-10 * the whole document *;
 [A]EP0763362  (XU RONGXIANG [CN]) [A] 1-10* page 3, line 50 - line 51; claim - *;
 [A]WO02067876  (NIAZI SARFARAZ K [US]) [A] 1-10 * paragraph [0010] - paragraph [0011] *;
 [Y]WO03001982  (XU RONGXIANG [US]) [Y] 1-10 * page 10 - page 12 * * page 14 - page 16 * * page 18 * * page 20 * * page 22 - page 23 * * page 48 * * page 98; example 3 *;
 [Y]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2008, no. 73, Database accession no. 2008-M33902, XP002679917 & CN101069753 A 20071114 (SHANGHAI MEIBAO LIFE SCI & TECHNOLOGY LTD) [Y] 1-10 * abstract *
International search[Y]CN86108951  (XU, RONGXIANG);
 [A]CN1891302  (XU RONGXIANG [CN]);
 [Y]  - "Effect of MEBO on the Healing of Diabetic Ulcer Wound at the Lower Extremities.", THE CHINESE JOURNAL OF BURNS WOUNDS & SURFACE ULCERS., (2008), vol. 20, no. 3, pages 217 - 218, XP008166435
 [Y]  - "Chinese Pharmacopoeia Commission.", NEW DRUG OFFICIAL STANDARD., (2004), no. 40, page 70
 [Y]  - "The manual of MEBO", URL: http://www.xinyao.com.cn/skin/catalog/other/20060215092232.htm2006
 [A]  - REN, HAIPING., "Treating 35 Cases Diabetic Feet Ulcer with MEBO and Insulin.", QINGDAO MEDICAL JOURNAL., (2007), vol. 39, no. 2, page 114, XP008166461
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.